| Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up R Glynne-Jones, L Wyrwicz, E Tiret, G Brown, C Rödel, A Cervantes, ... Annals of Oncology 28, iv22-iv40, 2017 | 1994 | 2017 |
| Imaging biomarker roadmap for cancer studies JPB O'connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ... Nature reviews Clinical oncology 14 (3), 169-186, 2017 | 1119 | 2017 |
| Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison G Brown, CJ Richards, MW Bourne, RG Newcombe, AG Radcliffe, ... Radiology 227 (2), 371-377, 2003 | 1093 | 2003 |
| Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study MERCURY Study Group Bmj 333 (7572), 779, 2006 | 975 | 2006 |
| Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging G Brown, AG Radcliffe, RG Newcombe, NS Dallimore, MW Bourne, ... Journal of British Surgery 90 (3), 355-364, 2003 | 934 | 2003 |
| Magnetic resonance imaging–detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience UB Patel, F Taylor, L Blomqvist, C George, H Evans, P Tekkis, P Quirke, ... Journal of Clinical Oncology 29 (28), 3753-3760, 2011 | 760 | 2011 |
| Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter … FGM Taylor, P Quirke, RJ Heald, B Moran, L Blomqvist, I Swift, ... Annals of surgery 253 (4), 711-719, 2011 | 738 | 2011 |
| Rectal carcinoma: thin-section MR imaging for staging in 28 patients G Brown, CJ Richards, RG Newcombe, NS Dallimore, AG Radcliffe, ... Radiology 211 (1), 215-222, 1999 | 657 | 1999 |
| Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic … E Al-Sukhni, L Milot, M Fruitman, J Beyene, JC Victor, S Schmocker, ... Annals of surgical oncology 19, 2212-2223, 2012 | 645 | 2012 |
| Diffusion MRI for prediction of response of rectal cancer to chemoradiation A Dzik-Jurasz, C Domenig, M George, J Wolber, A Padhani, G Brown, ... The Lancet 360 (9329), 307-308, 2002 | 589 | 2002 |
| Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the … FGM Taylor, P Quirke, RJ Heald, BJ Moran, L Blomqvist, IR Swift, ... Journal of clinical oncology 32 (1), 34-43, 2014 | 581 | 2014 |
| Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging–defined poor-risk rectal cancer I Chau, G Brown, D Cunningham, D Tait, A Wotherspoon, AR Norman, ... Journal of Clinical Oncology 24 (4), 668-674, 2006 | 567 | 2006 |
| EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum CJH van de Velde, PG Boelens, JM Borras, JW Coebergh, A Cervantes, ... European journal of cancer 50 (1), 1. e1-1. e34, 2014 | 565 | 2014 |
| Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study MERCURY Study Group Radiology 243 (1), 132-139, 2007 | 536 | 2007 |
| Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial Foxtrot Collaborative Group The lancet oncology 13 (11), 1152-1160, 2012 | 510 | 2012 |
| Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer NJ Smith, Y Barbachano, AR Norman, RI Swift, AM Abulafi, G Brown Journal of British Surgery 95 (2), 229-236, 2008 | 507 | 2008 |
| Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total … A Dewdney, D Cunningham, J Tabernero, J Capdevila, B Glimelius, ... Journal of Clinical Oncology 30 (14), 1620-1627, 2012 | 461 | 2012 |
| Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases S Frentzas, E Simoneau, VL Bridgeman, PB Vermeulen, S Foo, ... Nature medicine 22 (11), 1294-1302, 2016 | 440 | 2016 |
| Corrections to “Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up” R Glynne-Jones, L Wyrwicz, E Tiret, G Brown, C Rödel, A Cervantes, ... Annals of Oncology 29, iv263, 2018 | 405 | 2018 |
| Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial YJ Chua, Y Barbachano, D Cunningham, JR Oates, G Brown, ... The lancet oncology 11 (3), 241-248, 2010 | 402 | 2010 |
Professor Paris TekkisImperial College London, The Royal Marsden Hospital, Chelsea & Westminster HospitalVerified email at imperial.ac.uk
